Protecting Children from Foreign Mutilation Act
HB6876, titled the Protecting Children from Foreign Mutilation Act, would require the President to impose visa-related sanctions on certain foreign persons the President determines have performed, prescribed, or otherwise facilitated what the bill defines as “chemical or surgical mutilation” of United States minors. The bill targets foreign individuals who are members of the World Professional Association for Transgender Health, foreign physicians involved in such care, and owners or operators of medical facilities that provide it. Sanctions would make those individuals inadmissible to the United States, ineligible for visas or parole, and subject to automatic revocation of existing visas or entry documents.
The bill also directs the Secretary of State to create a process for receiving information about potentially sanctionable foreign persons and requires a report to Congress within 180 days describing implementation, the number of sanctioned persons, and any additional measures to discourage foreign persons from providing gender transitions to U.S. persons. It includes exceptions for compliance with U.N. headquarters obligations and other international obligations, a whistleblower-related exception for certain foreign persons who provide information to authorities, and a national security waiver.
The bill’s definitions are broad and central to its operation. It defines “chemical or surgical mutilation” to include puberty blockers, sex hormones, and certain surgeries when used to alter a person’s body so it no longer corresponds to the person’s sex, while excluding treatment for verifiable disorders of sexual development, treatment of complications from such interventions, care for other diagnosed bodily conditions, and detransition treatment. It defines “United States person” for purposes of the bill as a U.S. citizen, national, or lawful permanent resident under age 18.
Because the bill was only introduced and referred to the House Judiciary Committee, there is no recorded vote or committee transcript in the provided materials, so no formal legislative support or opposition is documented here. Based on the text, the measure appears strongly aligned with opponents of pediatric gender-affirming care and likely to be viewed as protective by supporters who frame such care as harmful, while critics would likely object to its characterization of medical treatment, its targeting of transgender health professionals and institutions, and its use of immigration sanctions as a policy tool.
If enacted, the bill would add a new federal sanctions regime tied to immigration law, authorizing the executive branch to deny entry, revoke visas, and bar parole for foreign persons connected to specified gender-related medical care for minors. It would affect the Immigration and Nationality Act by creating a new class of inadmissible foreign persons and by mandating automatic visa revocation for covered individuals. It would also impose new reporting and information-gathering duties on the Department of State and could indirectly affect foreign physicians, clinics, hospitals, pharmacies, and professional associations involved in transgender health care.
No votes or committee debate are provided, so there is no recorded legislative sentiment in the materials beyond the bill’s introduction and referral. The bill’s framing and sponsor list suggest support from lawmakers seeking to restrict pediatric gender-related medical interventions and to penalize foreign providers involved in them. At the same time, the bill’s language is highly controversial and likely to draw strong opposition from transgender rights advocates, medical professionals, and civil liberties groups who would view it as punitive and medically misleading.
The main points of contention are the bill’s definition of “chemical or surgical mutilation,” which explicitly includes puberty blockers, hormones, and surgeries used in gender transition care, and its application to foreign persons affiliated with transgender health organizations or providers. Supporters are likely to argue the bill protects minors from harmful procedures and deters foreign participation in such care, while opponents are likely to argue it stigmatizes medically accepted treatment, overreaches by using immigration sanctions, and could chill legitimate medical practice. The whistleblower exception, national security waiver, and exclusions for disorders of sexual development and other medical conditions may be cited by supporters as safeguards, but critics may see them as insufficient given the bill’s broad scope and politically charged terminology.